Approval · Notice of Compliance 33903 · 2024
TECVAYLI: Notice of Compliance 33903
Issued August 29, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33903
- Date
- August 29, 2024
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECVAYLI | Not yet assigned | — |
Medicinal ingredients
- TECLISTAMAB 30 MG per 3ML
- TECLISTAMAB 153 MG per 1.7ML